SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-003895
Filing Date
2021-11-10
Accepted
2021-11-10 07:03:30
Documents
14
Period of Report
2021-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcrr-20211110.htm   iXBRL 8-K 59924
2 EX-99.1 tcrr-ex99_1.htm EX-99.1 342949
3 GRAPHIC img238177558_0.jpg GRAPHIC 35409
  Complete submission text file 0000950170-21-003895.txt   597405

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcrr-20211110_pre.xml EX-101.PRE 11644
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcrr-20211110.xsd EX-101.SCH 2497
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcrr-20211110_lab.xml EX-101.LAB 19266
7 EXTRACTED XBRL INSTANCE DOCUMENT tcrr-20211110_htm.xml XML 4862
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Filer) CIK: 0001750019 (see all company filings)

IRS No.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38811 | Film No.: 211394350
SIC: 2836 Biological Products, (No Diagnostic Substances)